Post-vaccination RV-IgA concentration was predicted with modest accuracy (R2 of 37.2%; interquartile range [IQR] 31.4–42.5%)—an effect driven primarily by neonatal rotavirus infection (Fig. 5B). This evidence concerns the gene CD79A and Rotavirus infection.